Cu(I) and Cu(II) Complexes Based on Lonidamine-Conjugated Ligands Designed to Promote Synergistic Antitumor Effects-Reference-Cited by-同舟云学术

Cu(I) and Cu(II) Complexes Based on Lonidamine-Conjugated Ligands Designed to Promote Synergistic Antitumor Effects

Published:2022-03-14 Issue:12 Volume:61 Page:4919-4937
ISSN:0020-1669
Container-title:Inorganic Chemistry
language:en
Short-container-title:Inorg. Chem.

Author:

Del Bello Fabio¹^ORCID,Pellei Maura²^ORCID,Bagnarelli Luca²,Santini Carlo²^ORCID,Giorgioni Gianfabio¹^ORCID,Piergentili Alessandro¹^ORCID,Quaglia Wilma¹^ORCID,Battocchio Chiara³^ORCID,Iucci Giovanna³^ORCID,Schiesaro Irene³,Meneghini Carlo³^ORCID,Venditti Iole³^ORCID,Ramanan Nitya⁴,De Franco Michele⁵,Sgarbossa Paolo⁶^ORCID,Marzano Cristina⁵,Gandin Valentina⁵

Affiliation:

1. School of Pharmacy, Medicinal Chemistry Unit, University of Camerino, via S. Agostino 1, 62032 Camerino, Italy

2. School of Science and Technology, Chemistry Division, University of Camerino, via S. Agostino 1, 62032 Camerino, Italy

3. Department of Science, Roma Tre University, Via della Vasca Navale 79, 00146 Roma, Italy

4. Diamond Light Source, Harwell Science and Innovation Campus, Didcot OX11 0DE, U.K.

5. Department of Pharmaceutical and Pharmacological Sciences, University of Padova, via Marzolo 5, 35131 Padova, Italy

6. Department of Industrial Engineering, University of Padova, via Marzolo 9, 35131 Padova, Italy

Funder

Regione Lazio

Universit? degli Studi di Camerino

CERIC-ERIC Consortium

Publisher

American Chemical Society (ACS)

Subject

Inorganic Chemistry,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.inorgchem.1c03658

Reference88 articles.

1. Mechanism of antineoplastic activity of lonidamine

2. Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy

3. Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine

4. Targeting prostate cancer cell metabolism: impact of hexokinase and CPT-1 enzymes

5. The anti-tumour agent lonidamine is a potent inhibitor of the mitochondrial pyruvate carrier and plasma membrane monocarboxylate transporters

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure-dependent aggregation and ROS-generation in aqueous media of new cationic copper(I) complexes based on 1,5,3,7-diazadiphosphacyclooctanes;Inorganica Chimica Acta;2025-01

2. An experimental and theoretical study of coinage bond interaction in a copper(II)/potassium(I) Schiff base complex;Inorganica Chimica Acta;2024-12

3. Phenanthroline and phenyl carboxylate mixed ligand copper complexes in developing drugs to treat cancer;Journal of Inorganic Biochemistry;2024-11

4. Encapsulation of Cu(II) Terpyridine Complexes into Polymeric Nanoparticles for Enhanced Anticancer Therapy;Chemistry – A European Journal;2024-08-06

5. Trace elements in pancreatic cancer;Cancer Medicine;2024-07